ArticleStrahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]2023
[Enzalutamide vs active surveillance in patients with low-risk prostate cancer].
Jürgen Dunst et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.